Superior efficacy of insulin degludec/liraglutide versus insulin glargine U100 as add‐on to sodium‐glucose co‐transporter‐2 inhibitor therapy: A randomized clinical trial in people with uncontrolled type 2 diabetes

AIM: To investigate the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as add‐on to sodium‐glucose co‐transporter‐2 (SGLT2) inhibitor therapy. MATERIALS AND METHODS: In this 26‐week, phase IIIb, open‐label, parallel‐group, treat‐to‐ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Philis‐Tsimikas, Athena, Billings, Liana K., Busch, Robert, Portillo, Cristobal Morales, Sahay, Rakesh, Halladin, Natalie, Eggert, Sarah, Begtrup, Kamilla, Harris, Stewart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593861/
https://www.ncbi.nlm.nih.gov/pubmed/30761720
http://dx.doi.org/10.1111/dom.13666

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593861/
https://www.ncbi.nlm.nih.gov/pubmed/30761720
http://dx.doi.org/10.1111/dom.13666

Ejemplares similares